However, compared to αβ T cells, Vγ9Vδ2 T cells stand out by their broad tumor specificity without the need of engineering: They recognize the altered state of the tumor cell rather than a single tumor antigen—both through NK cell receptors and the γδ TCR. Here, KLRD1 is linked to neoplasm.